SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-144951
Filing Date
2024-05-22
Accepted
2024-05-22 16:10:12
Documents
17
Period of Report
2024-05-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d807494d8k.htm   iXBRL 8-K 32594
2 EX-16.1 d807494dex161.htm EX-16.1 2009
6 GRAPHIC g807494dsp05a.jpg GRAPHIC 8398
7 GRAPHIC g807494dsp05b.jpg GRAPHIC 4108
8 GRAPHIC g807494dsp05d.jpg GRAPHIC 7701
  Complete submission text file 0001193125-24-144951.txt   187687

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20240516.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240516_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240516_pre.xml EX-101.PRE 11259
21 EXTRACTED XBRL INSTANCE DOCUMENT d807494d8k_htm.xml XML 3656
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 24973314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)